The Innovation Pipeline: How Patents Drive Growth in Orthopedics

Innovation is the lifeblood of the orthopedic industry. From minimally invasive surgical techniques to next-generation biomaterials, constant progress fuels improved patient outcomes and market growth. But how can this innovation best be tracked and companies most likely to disrupt the status quo best be identified? One powerful tool lies within the seemingly obscure data collected by the U.S. Patent and Trademark Office’s (USPTO) patent application database.

Patents: A Window to the Future

Typically published 18 months after they’re filed, patent applications offer a unique glimpse into a company’s research and development pipeline. Application data provides insights into the technology areas that are attracting the most interest and identifies the key players driving innovation. Furthermore, unlike some industry databases with lower barriers to entry, the cost associated with filing a patent application creates a natural “hurdle” that reduces noise and focuses the data on serious innovators.

For example, a recent query of the USPTO database identified 1,882 published applications filed over the past five years that contain the terms “orthopedic” or “sports medicine” and fall within the Class 606 (Surgery) classification. This information provides a rich resource for understanding innovation industry trends.

Established Players Lead the Charge

The Pareto Principle, also known as the 80/20 rule, often holds true in patent applications. In our analysis, the top 14 applicants—primarily large established medical technology companies—accounted for a significant portion of the applications filed. Johnson & Johnson companies, including DePuy Synthes and Ethicon, topped the list with a combined 106 applications, followed by Medtronic’s various entities with 90 applications. This dominance shows the significant resources these companies are willing (and able) to dedicate to R&D.

The data, however, also reveals interesting pockets of innovation from smaller players. Companies like spine fusion device developer Carlsmed Inc. (16 applications) and orthopedic robot manufacturer Think Surgical (12 applications) demonstrate that agility and focus can be powerful drivers of invention. One particularly interesting outlier is IX Innovation LLC, a company with a unique role in the orthopedic innovation landscape. A portfolio firm of IntuitiveX, the Seattle entity describes itself as an intellectual property (IP) engine for creating and monetizing original IP in the surgical landscape. Last spring, the company received a U.S. patent for a robotic surgical system and implant placement technology. Specifically, the patent relates to methods, apparatuses, and systems to robotically insert implants like screws, rods, or other components. The patent details the advantages the robotic system provides to clinicians: more accurate screw insertion, automation of surgical procedure steps, reduced opportunity for human error, and potential remote surgical capabilities, among others.

“The advantages of the disclosed methods and systems include improved precision, stability, and dexterity in surgical procedures, automation of routine tasks, compensation for a surgeon’s lack of experience in a specific procedure, and enhanced control of insertion parameters,” IX Innovation Managing Partner Simon Robinson, said when the patent was awarded.

IX Innovation LLC stands out with a surprising 20 applications filed over the past five years. Unlike the traditional medical device companies, IX Innovation is not focused on internal R&D; rather, it acts as a catalyst for innovation, helping entrepreneurs and young companies in the life sciences field bring their ideas from concept to commercialization. This model enables IX Innovation to tap into a vast creativity pool, potentially leading to disruptive technologies in the orthopedic space.

Academic institutions also play a vital role in driving innovation. My analysis identified MIT (18 applications), the University of Texas System (13 applications), the University of Washington (four applications), the University of Pennsylvania (four applications), and the University of Arizona (four applications) as the top five university filers in orthopedics and sports medicine. These institutions foster groundbreaking research and often act as a breeding ground for future industry leaders.

MIT has consistently been a leading source of patent-protected innovation. Last year, the institution outpaced all other single-campus universities in the United States in granted patents, with 365 issued by the USPTO. MIT has led its cohorts in granted utility patents for the past decade—only the University of California system, which comprises 10 campuses and six academic health centers throughout the state, had more and is ranked No. 1 overall.

“Our collaborative efforts ensure the innovations born here at MIT make a difference across the globe, addressing some of the most pressing challenges of our time,” MIT Technology Licensing Office Executive Director Lesley Millar-Nicholson said in announcing the university’s ranking.

Talent Retention Is Key

Drilling down further into patent applications reveals the identities of the most prolific individual inventors at the top filing institutions. These individuals—like Jeffrey Roh at IX Innovations (23 applications), Feng Zhang at MIT (15 applications), Frederick Shelton, IV at Ethicon (11 applications), and Roy Lim at Medtronic (11 applications)—represent the intellectual horsepower driving innovation. From an M&A acquisitions perspective, retaining this top talent is crucial for maintaining a company’s technological and competitive edge.

Analyzing the titles of all the applications in a patent search using a word cloud visualization tool reveals the most frequently occurring technology areas. This provides valuable insights into where the industry is focusing its efforts. For instance, terms like “robotic surgery,” “soft tissue fixation,” and “patient-specific” suggest a strong focus on minimally invasive techniques, patient-specific solutions, and patient monitoring.

Patent Power and Limitations

It is important to acknowledge that patent application data has its limitations. Companies can file under various entities, and applications still need to be examined and granted to become official patents. However, compared to other data sources, the USPTO database offers a robust and objective view of innovation trends. By examining application data, analysts can identify emerging technologies, track the activity of key players, and spot talented inventors who are shaping the future of orthopedics.

This glimpse into the innovation pipeline highlights the critical role patents play in the orthopedic industry. For medical device startups, securing patents is not just about protecting intellectual property—it’s about establishing credibility, attracting investors, and ultimately increasing a company’s valuation. 

---

Eric Heinz is a former medtech executive and founder/CEO of Heinz Ventures, a medtech venture studio. He has broad functional experience across product development engineering, marketing, strategy, and business development. He currently is a consulting partner at MedWorld Advisors, and can be reached at [email protected].